TCL Archive In Brief: Revlon Foundation Gives $7.5 Million To UCA for Women’s Health Research, Breast Cancer December 16, 1994
TCL Archive ACCC Seeks Greater Role In Clinical Research Priorities; Suggests Up To 400 Cancer Program April 13, 1979
TCL Archive FDA Approves Gemzar For Ovarian Cancer, Contradicting ODAC Recommendation; Continues Agency Trend to Recognize Progression-Free Survival As An Endpoint. July 21, 2006
TCL Archive NIH Grant Funding to Use Percentiles Instead Of Priority Scores; Minimal Impact Seen By NCI January 22, 1988
